Consensus AstraZeneca PLC Nasdaq Stockholm

Equities

AZN

GB0009895292

Market Closed - Nasdaq Stockholm Other stock markets 11:29:46 2024-05-24 am EDT			5-day change	1st Jan Change
1,672 ^SEK	-1.33%		+1.76%	+23.57%

May. 24	Innate Pharma: five abstracts selected for ASCO	CF
May. 24	Adherium Partners with AstraZeneca for Hailie Smartinhaler Trial	MT

Evolution of the average Target Price on AstraZeneca PLC

Price target over the last 5 years

History of analyst recommendation changes

39c8b537b4786417a3b2c4f8bf1.Wu006Hb9h4TgaxEjGabysS43vMZzj0qolrO7LpKW3Vs.Mpl_txrLzMmOHWERT5Gf-nFNjr4L_zLC0sD6aPvumTloug2MFZnA0YcSdg~c19c051aa06b6e03de75eddf45265247

Analyst Recommendations on AstraZeneca PLC

Stifel Raises AstraZeneca PT, Maintains Buy Rating	May. 22	MT
ASTRAZENECA : Oddo BHF raises its target slightly	May. 22	CF
Barclays cuts NextEnergy but lifts JLEN	May. 22	AN
ASTRAZENECA : Gets a Neutral rating from Deutsche Bank	May. 22	ZD
ASTRAZENECA : JP Morgan keeps its Buy rating	May. 22	ZD
ASTRAZENECA : Receives a Sell rating from UBS	May. 21	ZD
ASTRAZENECA : Gets a Buy rating from JP Morgan	May. 20	ZD
ASTRAZENECA : UBS reiterates its Sell rating	May. 15	ZD
ASTRAZENECA : Buy rating from JP Morgan	May. 14	ZD
Jefferies Lifts AstraZeneca PT, Maintains Hold Rating	May. 08	MT
ASTRAZENECA : Jefferies sticks Neutral	May. 08	ZD
UBS raises Centrica to 'buy' from 'neutral	May. 08	AN
Berenberg Raises AstraZeneca PT, Keeps Rating at Buy	May. 07	MT
ASTRAZENECA : Berenberg keeps its Buy rating	May. 07	ZD
AstraZeneca target raised; Antofagasta lowered	May. 07	AN
ASTRAZENECA : Deutsche Bank gives a Neutral rating	Apr. 30	ZD
ASTRAZENECA : JP Morgan maintains a Buy rating	Apr. 29	ZD
Deutsche Bank likes Frasers; Barclays cuts JD	Apr. 29	AN
ASTRAZENECA : DZ Bank sticks Neutral	Apr. 26	ZD
ASTRAZENECA : UBS keeps a Sell rating	Apr. 26	ZD
ASTRAZENECA : Deutsche Bank remains Neutral	Apr. 26	ZD
ASTRAZENECA : Gets a Buy rating from Barclays	Apr. 26	ZD
Barclays Raises AstraZeneca PT, Affirms at Overweight	Apr. 26	MT
Peel Hunt cuts ConvaTec to 'reduce'	Apr. 26	AN
ASTRAZENECA : Strong Q1 raises hopes of a guidance upgrade	Apr. 25

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

156.7 USD

Average target price

170.1 USD

Spread / Average Target

+8.53%

High Price Target

220.2 USD

Spread / Highest target

+40.49%

Low Price Target

131.3 USD

Spread / Lowest Target

-16.24%

Consensus detail

Consensus revision (last 18 months)

Analysts covering AstraZeneca PLC

Stifel Nicolaus
DEUTSCHE BANK RESEARCH	Emmanuel Papadakis
JPMORGAN	James Gordon
UBS	Matthew Weston
Jefferies & Co.
JEFFERIES	Peter Welford
BERENBERG	Luisa Hector
Barclays
DZ BANK	Elmar Kraus
alphavalue	Abhishek Raval
BERNSTEIN RESEARCH	Justin Smith
Deutsche Bank Securities
Bernstein
B. Riley
RBC Capital Markets
Berenberg Bank
BMO Capital
CREDIT SUISSE	Dominic Lunn
HSBC
Argus
Morgan Stanley
GOLDMAN SACHS	Keyur Parekh
Bank of America Securities/Merrill Lynch
Danske Bank Group
Kepler Capital Markets
Kepler Cheuvreux
DEUTSCHE BANK	Emmanuel Papadakis
SVB Leerink
Bryan, Garnier & Co.
Societe Generale
Liberum Capital
ODDO BHF
BANK OF AMERICA (BOFA)	Sachin Jain

Ratings for AstraZeneca PLC

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar